论文信息 - A prospective randomized phase II trial of GM-CSF priming to prevent topotecan-induced neutropenia in chemotherapy-naive patients with malignant melanoma or renal cell carcinoma. - 字舞流文

A prospective randomized phase II trial of GM-CSF priming to prevent topotecan-induced neutropenia in chemotherapy-naive patients with malignant melanoma or renal cell carcinoma.

E. Korn | D. Longo | M. Sznol | W. Urba | J. Janik | W. Sharfman | L. Miller | B. Curti | K. Conlon | B. Gause | J. Smith | D. Stevens